Implantable contact lenses (ICLs) correct vision in much the same way that external contact lenses do, except ICLs are placed inside the eye where they reside permanently to improve vision. They are permanent and are not visible to others. ICLs are also similar to intraocular lenses that are used during cataract surgery to replace the eye's natural lens. During ICL surgery, however, the natural lens is not removed. The natural lens is kept in the eye and works with the ICL to correct vision. ICLs give all nearsighted patients, particularly those with higher levels of correction (thicker glasses), a second option and alternative to laser vision correction. Unlike LASIK, patients with ICLs do not experience increased dry eye symptoms, glare, halos, fluctuating vision, and myopic regression.
Implantable contact lenses are inserted through a small incision in the cornea and placed behind the iris and in front of the natural lens. The ICL procedure is a ten minute, FDA-approved, virtually pain free procedure with a 95 percent success rate.
The outpatient procedure is performed in our on-site, office-based New York State licensed, and AAAHC accredited surgery center. The implantable contact lens procedure is performed under sedation in about 10 minutes. Improved vision is often noticed in 24-48 hours, and patients usually heal fully within one week.
Yes. Over 200,000 implants have been performed worldwide with a success rate of 99%. Although all surgical procedures carry some risk of complications, ICLs have a track record of safety. Unlike LASIK, the ICL procedure is reversible and the cornea is not altered.
The Visian ICL is designed to be completely unobtrusive after it is put in place. It stays in position by itself and does not interact with any of the eye's structures.
One advantage of the Visian ICL is that it offers treatment flexibility. If your vision changes dramatically after receiving the implant, your surgeon can remove or replace it. If necessary, another procedure can be performed at any time. The implant does not treat presbyopia (difficulty with reading in people 40 years and older), but like LASIK, you can use reading glasses as needed.
Usually, the best candidates for implantable contact lenses are between the ages of 21 and 45, with moderate to severe myopia (Nearsightedness), less than 2.5 diopters of astigmatism, are not pregnant or breastfeeding, and have proper anterior chamber depth. Many people who are not good candidates for LASIK due to high myopia, dry eyes, or thin corneas are excellent candidates for ICLs. For a thorough analysis of whether you are a good candidate for ICLs, make an appointment with Dr. Siedlecki.
Implantable Contact Lenses have many benefits over other types of vision correction.
Implantable contact lenses are convenient. There is no contact lens discomfort, no contact lens solutions and supplies, no glasses to grab first thing in the morning, and no further glasses or contacts to purchase. Without the bother of glasses and contacts, individuals with implanted contact lenses (ICLs) are more able to thoroughly enjoy activities like swimming.
People with a high degree of nearsightedness (myopia), have thin corneas, or severe dry eyes usually are not good candidates for LASIK. Implantable contact lenses are superior in their ability to correct severe degrees of refractive errors. They can permanently improve the vision of people with moderate to severe nearsightedness and farsightedness.
One of the greatest benefits of implantable contact lenses over LASIK is that they do not physically alter your cornea.
Unlike LASIK, the procedure is entirely reversible. Although the Visian ICL is intended to remain in place permanently, a qualified ophthalmologist can remove the implant if necessary. Patients feel comfortable undergoing a surgical procedure they know can be reversed.
Patients who undergo LASIK surgery often develop problems with dry eyes after the procedure. This does not occur with implantable contact lenses. Unlike traditional contact lenses, implantable contact lenses are protected from normal wear and tear, and do not have to be replaced. The ICLs are protected from dust and dirt that typically cause dryness in traditional contacts. Patients with ICL experience no long term regression in their vision like some LASIK patients, and they do not experience fluctuating vision or halos and glare.
No surgical procedure is without risk, but when complications occur, they are usually minor. Patients rarely experience complications with ICLs and when they do occur, they are typically minor. As with any surgery, there are complications, and you should talk with our doctors about the risks and benefits of the ICL procedure.
The Visian ICL™ by STAAR Surgical is an insertable contact lens used to correct myopia (nearsightedness) in adults aged 21-45 without altering the cornea. It is the only minimally-invasive foldable lens available in the U.S. Made of a patented collagen-containing material called collamer, the Visian ICL is highly biocompatible, meaning it can be implanted in the eye with minimal risk of rejection.
Over 17 years of research and development has made the Visian ICL a leader in phakic IOL technology. The Visian ICL procedure was approved by the FDA (Federal Drug Administration) in 2005. There have been over 200,000 Visian ICL implants performed worldwide. When asked about the procedure, over 99% were highly satisfied.
The ICL's location allows it to provide excellent quality of vision and also ensures that it is invisible to the patient and others. The ICL can be removed or replaced at any time, and patients can wear glasses or contact lenses or choose to have other procedures done with the ICL in place.
Learn more about the Visian ICL at www.visianinfo.com.